- Earth Sciences - 18:02 Water Safety Update - Boil order lifted for Hyde Park
- Architecture - Aug 29 Water Safety Notice for Hyde Park
- Medicine - Aug 29 UCLA stem cell scientist and anti- bullying advocate to be on ESPN
- Business - Aug 28 Four Berkeley grads join White House Council of Economic Advisers
- Medicine - Aug 28 U of T-designed microchip predicts donor lung viability
- Arts - Aug 28 Hip- hop: Undergrads, local youth partner to explore genre
- Medicine - Aug 28 Antibody- making bacteria promise drug development
- Pedagogy - Aug 28 Garden offers living library of weeds, poisonous plants
- Chemistry - Aug 28 Cornell spinoff Novomer receives national award
- Physics - Aug 28 Seeing Quantum Motion
- Microtechnics - Aug 28 Secret to steady drone cameras in swans
- Agronomy - Aug 28 Millet Project shows grain isn’t just for the birds
Biomarkers assist in detecting life-threatening kidney injury after cardiac surgery
Following heart surgery, patients commonly experience acute kidney injury (AKI) and a progressive loss of kidney function. But a Yale-led study identifies specific blood and urine markers that can predict which patients will suffer these serious complications. The findings suggest that early detection and better patient monitoring could prevent kidney deterioration. The study appears online in the Journal of the American Society of Nephrology.
Acute kidney injury is a frequent complication of cardiac surgery that may lead to several adverse outcomes, including higher patient mortality. Previous studies have shown that several biomarkers can forecast early-onset AKI after cardiac surgery. However, most episodes of AKI are transient and will last only for a few days. Just 10 to 15 percent of patients will progress to severe AKI. Until now, there have been no effective tools to predict the risk of progressively worsening kidney function at the time of early-onset AKI.
The Yale-led research team, along with researchers from other institutions in the United States and Canada, are known as the Translational Research Investigating Biomarker End-Points in AKI consortium (TRIBE-AKI), a multidisciplinary group of academic investigators with expertise in pre-clinical, translational, epidemiologic and health services research.
The TRIBE-AKI consortium evaluated blood and urine samples of 380 cardiac surgery patients on the day they were diagnosed with AKI, and found that one blood and two urine biomarkers (blood neutrophil gelatinase-associated lipocalin, urine IL-18, and urine albumin/creatinine ratio) forecast the future progressive deterioration in kidney injury as well as adverse patient outcomes.
"Daily monitoring of these biomarkers after cardiac surgery can provide us with an earlier window to intervene in cases where patients will have continued deterioration of their kidney function after surgery," said lead author and principal investigator Chirag Parikh, M.D. Ph.D., director of the Program of Applied Translational Research and associate professor of nephrology at Yale School of Medicine and the Veterans Affairs Medical Center.
Other authors are Jay L. Koyner of the University of Chicago, Amit X. Garg and Heather Thiessen-Philbrook of the University of Western Ontario, Steven G. Coca and Kyaw Sint of Yale, Uptal D. Patel of Duke, and Michael G. Shilpak of the University of California San Francisco for the TRIBE-AKI Consortium.
Last job offers
- Pedagogy/Education Science - 29.8
Speech and Hearing Sciences - Assistant Professor (AA13323)
- Social Sciences - 29.8
Communication - Assistant Professor (AA13297)
- Arts and Design - 29.8
Assistant / Associate Professor of Instrumental Music Education
- Literature/Linguistics - 29.8
Leonard B. Kaye Chair in Hebrew and Comparative Literature
- - 28.8
- Medicine/Pharmacology - 28.8
Surgery- Asst/Assoc Prof-Plastic Surgeon
- Business/Economics - 28.8
College of Media: Assistant / Associate Professor - Charles H. Sandage Department of Advertising (F1500075)...
- Social Sciences - 28.8
School of Social Work: Clinical Assistant Professor for Field Education (F1500076)